TB Biosciences is an early-stage medical diagnostics company developing a point-of-care test for active tuberculosis.
Description
TB Biosciences, Inc. is an early stage development medical diagnostics company founded in June 2013 to develop a rapid point-of-care tuberculosis test that meets performance standards around the world. The goal of TB Biosciences is to commercialize a simple to operate and use tuberculosis test that replaces the 125 year old sputum smear test. The Company is using an array of patented peptides developed and exclusively licensed from the NYU School of Medicine.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Bethlehem, Pennsylvania, United States, North America
Founded on
June 1, 2013
Closed on
December 1, 2018
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Cannot Access, No Way
Sign in for full access
Founders
Daniel Malamud, R. Sam Niedbala, Suman Laal, Susan Zolla, William Abrams